title: Molecular interactions between fenoterol stereoisomers and derivatives and the β₂-adrenergic receptor binding site studied by docking and molecular dynamics simulations.
abstract: The β2 adrenergic receptor (β2-AR) has become a model system for studying the ligand recognition process and mechanism of the G protein coupled receptors activation. In the present study stereoisomers of fenoterol and some of its derivatives (N = 94 molecules) were used as molecular probes to identify differences in stereo-recognition interactions between β2-AR and structurally similar agonists. The present study aimed at determining the 3D molecular models of the fenoterol derivative-β2-AR complexes. Molecular models of β2-AR have been developed by using the crystal structure of the human β2-AR T4 lysozyme fusion protein with bound (S)-carazolol (PDB ID: 2RH1) and more recently reported structure of a nanobody-stabilized active state of the β2-AR with the bound full agonist BI-167107 (PDB ID: 3P0G). The docking procedure allowed us to study the similarities and differences in the recognition binding site(s) for tested ligands. The agonist molecules occupied the same binding region, between TM III, TM V, TM VI and TM VII. The residues identified by us during docking procedure (Ser203, Ser207, Asp113, Lys305, Asn312, Tyr308, Asp192) were experimentally indicated in functional and biophysical studies as being very important for the agonist-receptor interactions. Moreover, the additional space, an extension of the orthosteric pocket, was identified and described. Furthermore, the molecular dynamics simulations were used to study the molecular mechanism of interaction between ligands ((R,R')- and (S,S')-fenoterol) and β2-AR. Our research offers new insights into the ligand stereoselective interaction with one of the most important GPCR member. This study may also facilitate the design of improved selective medications, which can be used to treat, prevent and control heart failure symptoms.
authors.affiliation: Laboratory of Medicinal Chemistry and Neuroengineering, Medical University of Lublin, ul. Chodzki 4a, 20-093, Lublin, Poland.
authors.forename: Anita
authors.initials: A
authors.lastname: Plazinska
authors.forename: Michal
authors.initials: M
authors.lastname: Kolinski
authors.forename: Irving W
authors.initials: IW
authors.lastname: Wainer
authors.forename: Krzysztof
authors.initials: K
authors.lastname: Jozwiak
mesh_terms: D058666:Adrenergic beta-2 Receptor Agonists / Q000737:chemistry; D001665:Binding Sites; D005280:Fenoterol / Q000031:analogs & derivatives / Q000737:chemistry*; D006801:Humans; D008024:Ligands; D008958:Models, Molecular; D062105:Molecular Docking Simulation; D056004:Molecular Dynamics Simulation; D018343:Receptors, Adrenergic, beta-2 / Q000737:chemistry*; D043562:Receptors, G-Protein-Coupled / Q000378:metabolism; D013237:Stereoisomerism
chemical_list: D058666:Adrenergic beta-2 Receptor Agonists; D008024:Ligands; D018343:Receptors, Adrenergic, beta-2; D043562:Receptors, G-Protein-Coupled; D005280:Fenoterol
references.citation: J Am Chem Soc. 2010 Aug 25;132(33):11443-5
references.pmid: 20669948
references.citation: J Med Chem. 2008 Aug 28;51(16):4978-85
references.pmid: 18680279
references.citation: J Chem Theory Comput. 2009 Mar 10;5(3):615-26
references.pmid: 26610227
references.citation: Bioorg Med Chem. 2010 Jan 15;18(2):728-36
references.pmid: 20036561
references.citation: Nat Protoc. 2010 Apr;5(4):725-38
references.pmid: 20360767
references.citation: Nature. 2011 Jul 19;477(7366):549-55
references.pmid: 21772288
references.citation: J Biol Chem. 1988 Jul 25;263(21):10267-71
references.pmid: 2899076
references.citation: Science. 2007 Nov 23;318(5854):1258-65
references.pmid: 17962520
references.citation: Structure. 2008 Jun;16(6):897-905
references.pmid: 18547522
references.citation: Acta Pharmacol Sin. 2012 Mar;33(3):335-41
references.pmid: 22286918
references.citation: J Allergy Clin Immunol. 1999 Aug;104(2 Pt 2):S42-6
references.pmid: 10452787
references.citation: J Comput Chem. 2004 Oct;25(13):1656-76
references.pmid: 15264259
references.citation: BMC Biol. 2007 May 08;5:17
references.pmid: 17488521
references.citation: J Biol Chem. 1989 Aug 15;264(23):13572-8
references.pmid: 2547766
references.citation: J Comput Chem. 2005 Dec;26(16):1701-18
references.pmid: 16211538
references.citation: Proc Natl Acad Sci U S A. 2004 May 18;101(20):7594-9
references.pmid: 15126668
references.citation: Mol Pharmacol. 1998 Oct;54(4):616-22
references.pmid: 9765503
references.citation: Biochem Pharmacol. 2010 Jun 1;79(11):1610-5
references.pmid: 20144591
references.citation: Proteins. 2007;69 Suppl 8:108-17
references.pmid: 17894355
references.citation: Acta Crystallogr D Biol Crystallogr. 2004 Aug;60(Pt 8):1355-63
references.pmid: 15272157
references.citation: Mol Pharmacol. 1993 Jul;44(1):111-4
references.pmid: 8101966
references.citation: Br J Pharmacol. 1999 Sep;128(2):272-4
references.pmid: 10510435
references.citation: Drug Discov Today. 2006 Feb;11(3-4):160-4
references.pmid: 16533714
references.citation: J Mol Biol. 2009 Oct 2;392(4):1102-15
references.pmid: 19665031
references.citation: Nature. 2011 Jan 13;469(7329):175-80
references.pmid: 21228869
references.citation: Chirality. 2011;23 Suppl 1:E1-6
references.pmid: 21618615
references.citation: J Mol Recognit. 2009 Jul-Aug;22(4):307-18
references.pmid: 19353579
references.citation: Nucleic Acids Res. 2007;35(10):3375-82
references.pmid: 17478507
references.citation: Biochim Biophys Acta. 2007 Apr;1768(4):794-807
references.pmid: 17188232
references.citation: Acta Biochim Pol. 2004;51(2):349-71
references.pmid: 15218533
references.citation: Mol Pharmacol. 1998 Jan;53(1):128-34
references.pmid: 9443940
references.citation: J Med Chem. 2007 Jun 14;50(12):2903-15
references.pmid: 17506540
references.citation: Methods. 2007 Apr;41(4):475-88
references.pmid: 17367719
references.citation: Proc Natl Acad Sci U S A. 1996 Aug 20;93(17):9276-81
references.pmid: 8799191
references.citation: J Med Chem. 2006 Jun 1;49(11):3315-21
references.pmid: 16722650
references.citation: Mol Pharmacol. 1999 Nov;56(5):875-85
references.pmid: 10531390